Iontophoresis disc pain blocker
OwnerWilliam R. Deagleinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerWilliam R. Deagleinventor
Estimating the term…
Treatment of pain syndromes utilizes a topical polypharmaceutical preparation of phenoxybenzamine, ketamine, gabapentin, nifedipine, carbamazepine, or combinations of them. Other suitable components are blockers of sympathetic alpha 1, 2 and other receptors, NMDA receptor blockers, GABA receptor blockers, AMPA receptor blockers, nitric oxide synthase receptor blockers, calcium channel blockers, ACDP receptor blockers, prostaglandin and leukotriene blockers, substance P blockers, bradykinin and neurotenin as well as other peptide blockers, and TNF alpha blockers. Recommended delivery is by locating a predetermined neurodermal point and locating a gel patch over the predetermined neurodermal point. Iontophoresis then delivers the pharmaceutical agent from the gel patch.
A topically effective polypharmaceutical composition consisting essentially of a combination of pharmaceutical agents consisting of an effective dosage of phenoxybenzamine, ketamine, and gabapentin carried in a pluronic lecithin organogel as a topical vehicle, wherein said dosage is a therapeutically effective amount for treating chronic pain by producing a blockade of initiation and propagation of the pain stimulus in the Langerhans and other neuroendocrine vascular structures of the superficial and deep dermis.
A method of treating pain by producing a producing a blockade of initiation and propagation of the pain stimulus in the Langerhans and other neuroendocrine vascular structures of the superficial and deep dermis of a humnan or animal subject in need of such treatment, comprising:
Dependencies are inferred from the claim text.